Ultrafiltration in Acute Heart Failure

Congestion is the predominant cause of more than 1 million annual heart failure hospitalisations and recurrent fluid overload predicts poor outcomes. Unresolved congestion trumps serum creatinine increases in predicting adverse heart failure outcomes. No pharmacological approach for acute heart fail...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	Maria Rosa Costanzo
Formato:	article
Lenguaje:	EN
Publicado:	Radcliffe Medical Media 2019
Materias:	Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/24dd25cab9aa412fbd376b3ba0ac8a85
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:24dd25cab9aa412fbd376b3ba0ac8a85
record_format	dspace
spelling	oai:doaj.org-article:24dd25cab9aa412fbd376b3ba0ac8a852021-12-04T16:00:50ZUltrafiltration in Acute Heart Failure10.15420/cfr.2018.29.22057-75592057-7540https://doaj.org/article/24dd25cab9aa412fbd376b3ba0ac8a852019-01-01T00:00:00Zhttps://www.cfrjournal.com/articles/ultrafiltration-acute-heart-failurehttps://doaj.org/toc/2057-7540https://doaj.org/toc/2057-7559Congestion is the predominant cause of more than 1 million annual heart failure hospitalisations and recurrent fluid overload predicts poor outcomes. Unresolved congestion trumps serum creatinine increases in predicting adverse heart failure outcomes. No pharmacological approach for acute heart failure has reduced these deleterious consequences. Simplified ultrafiltration devices permit fluid removal in lower acuity hospital settings, but results regarding safety and efficacy have been variable. However, adjustment of ultrafiltration rates to patients’ vital signs and renal function has been associated with more effective decongestion and fewer heart failure events. Many aspects of ultrafiltration, including patient selection, fluid removal rates, venous access, prevention of therapy- related complications and costs, require further investigation.Maria Rosa CostanzoRadcliffe Medical MediaarticleDiseases of the circulatory (Cardiovascular) systemRC666-701ENCardiac Failure Review , Vol 5, Iss 1, Pp 9-18 (2019)
institution	DOAJ
collection	DOAJ
language	EN
topic	Diseases of the circulatory (Cardiovascular) system RC666-701
spellingShingle	Diseases of the circulatory (Cardiovascular) system RC666-701 Maria Rosa Costanzo Ultrafiltration in Acute Heart Failure
description	Congestion is the predominant cause of more than 1 million annual heart failure hospitalisations and recurrent fluid overload predicts poor outcomes. Unresolved congestion trumps serum creatinine increases in predicting adverse heart failure outcomes. No pharmacological approach for acute heart failure has reduced these deleterious consequences. Simplified ultrafiltration devices permit fluid removal in lower acuity hospital settings, but results regarding safety and efficacy have been variable. However, adjustment of ultrafiltration rates to patients’ vital signs and renal function has been associated with more effective decongestion and fewer heart failure events. Many aspects of ultrafiltration, including patient selection, fluid removal rates, venous access, prevention of therapy- related complications and costs, require further investigation.
format	article
author	Maria Rosa Costanzo
author_facet	Maria Rosa Costanzo
author_sort	Maria Rosa Costanzo
title	Ultrafiltration in Acute Heart Failure
title_short	Ultrafiltration in Acute Heart Failure
title_full	Ultrafiltration in Acute Heart Failure
title_fullStr	Ultrafiltration in Acute Heart Failure
title_full_unstemmed	Ultrafiltration in Acute Heart Failure
title_sort	ultrafiltration in acute heart failure
publisher	Radcliffe Medical Media
publishDate	2019
url	https://doaj.org/article/24dd25cab9aa412fbd376b3ba0ac8a85
work_keys_str_mv	AT mariarosacostanzo ultrafiltrationinacuteheartfailure
_version_	1718372781023821824

Ultrafiltration in Acute Heart Failure

Ejemplares similares